title: [Plasma levels of halofantrine during two therapeutic sessions at a 7 day interval].
authors.forename: A
authors.initials: A
authors.lastname: Keundjian
authors.forename: J E
authors.initials: JE
authors.lastname: Touze
authors.forename: J
authors.initials: J
authors.lastname: Bernard
authors.forename: E
authors.initials: E
authors.lastname: Bertherat
authors.forename: J L
authors.initials: JL
authors.lastname: Soares
mesh_terms: D000328:Adult; D000962:Antimalarials / Q000008:administration & dosage / Q000097:blood* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D006801:Humans; D016778:Malaria, Falciparum / Q000097:blood* / Q000188:drug therapy; D010616:Phenanthrenes / Q000008:administration & dosage / Q000097:blood* / Q000627:therapeutic use
chemical_list: D000962:Antimalarials; D010616:Phenanthrenes; C044961:1,3-dichloro-6-trifluoromethyl-9-phenanthryl-3-(n-butyl)aminopropanol; C023768:halofantrine
vernacular_title: Concentrations plasmatiques de l'halofantrine lors de 2 cures thérapeutiques à 7 jours d'intervalle.